There is some debate over whether this qualifies as a blue-collar job. After all, ATCs usually earn more than $100,000 per year, work in an office-type surrounding, and supervise airline pilots, who themselves earn six-figure salaries.
Good news everyone! The Patent Office has granted a patent on a cure for cancer. Last December, the Patent Office issued Patent No. 8,609,158 on a âpotent drugâ that ârebukes cancer, cancer cells, and kills cancer.â According to the patent, this drug cures a litany of other maladies.
PD-1, short for Programmed Death 1 (PD-1) receptor, has two ligands, PD-L1 and PD-L2. This checkpoint is the target of Merck & Co.'s melanoma drug Keytruda, which gained FDA approval in September 2014. An advantage of targeting PD-1 is that it can restore immune function in the tumor microenvironment.